
Session: Flexible Facilities Democratization of Biosimilars' Opportunity in Emerging Markets
Speaker: Abdullah Baaj, M.D., PharmD, CEO, Boston Oncology
As far as new products like biosimilars, which rely on a very low cost of manufacturing in order to be competitive, flexible facilities and technologies are lowering manufacturing costs. Want to learn more about biomanufacturing options for production of biosimilars in emerging markets? Join us February 24-25, 2014 in Berkley, CA for IBC's 2nd Annual Flexible Facilities conference.
To view our full program, download our agenda. Use code FLEX14BLOG to receive 20% off of the standard rate when you register. We hope to see you this February!
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment